DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Léger JM, Viala K, Nicolas G , et al; RIMAG Study Group (France and Switzerland).
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy.
Neurology 2013;
80 (24) 2217-2225
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.